GENinCode UK Ltd. (GB:GENI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
GENinCode Plc, a predictive genetics firm targeting cardiovascular and ovarian cancer prevention, has dispatched its 2023 Annual Report and AGM notice to shareholders. The documentation is accessible on the company’s website, with the AGM slated for 27 June 2024 at Cavendish Capital Markets in London. GENinCode continues to expand its innovative risk assessment technology in the UK, Europe, and the US.
For further insights into GB:GENI stock, check out TipRanks’ Stock Analysis page.
